Recently, we demonstrated that KLK1 supplementation during cerebral ischemia can inhibit the excessive activation of KKS system induced by reperfusion injury, thereby reducing blood–brain barrier damage and protecting the neurovascular unit [13]. This evidence concerns the gene KLK1 and brain ischemia.